Fundraising Fox
January Therapeutics
San Diego, US · Founded 2016 · Delaware corporation · 1 employees on LinkedIn
Find your way into January Therapeutics
Sign up to see every warm intro you have to January Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the January Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RJ
Robin JackmanFounder and CEO, COO2016–2021Robin Jackman has spent two decades in biopharmaceutical strategy, finance, and business development, with experience across drug discovery, clinical development, and M&A transactions. He has held leadership roles overseeing oncology programs, orphan drug development, nanoparticle platform technology, and early-stage critical care therapeutics from preclinical stages through clinical trials.
Board
SE
Samuel EllisBoard director
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 2 rounds · 2017–2019
▶$1.2MraisedFeb 2019 · 13 investors · BiotechnologyRule 506(b)
▶$1.2MraisedFeb 2019 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Samuel EllisDirector
- David MizrahiDirector
- Jason KahanaExecutive Officer, Director
- Robin JackmanExecutive Officer, Director
- Offering amount
- $1.4M
- Amount sold
- $1.2M
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$375KraisedJun 2017 · 2 investors · BiotechnologyRule 506(b)
▶$375KraisedJun 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robin JackmanExecutive Officer, Director
- Samuel EllisDirector
- Jason KahanaExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $375K
- Minimum investment
- $1
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has January Therapeutics raised?
- January Therapeutics has disclosed $1.6M raised across 2 rounds.
- Where is January Therapeutics headquartered?
- January Therapeutics is headquartered in San Diego, US.